Matches in Wikidata for { <http://www.wikidata.org/entity/Q66066219> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- Q66066219 description "clinical trial" @default.
- Q66066219 description "ensayu clínicu" @default.
- Q66066219 description "klinisch onderzoek" @default.
- Q66066219 description "клінічне випробування" @default.
- Q66066219 name "A Study of Heterologous Vaccine Regimen of Adenovirus Serotype 26 Mosaic4 Human Immunodeficiency Virus(Ad26.Mos4.HIV), Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1 Infection Among Cis-gender Men and Transgender Individuals Who Have" @default.
- Q66066219 name "A Study of Heterologous Vaccine Regimen of Adenovirus Serotype 26 Mosaic4 Human Immunodeficiency Virus(Ad26.Mos4.HIV), Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1 Infection Among Cis-gender Men and Transgender Individuals Who Have" @default.
- Q66066219 type Item @default.
- Q66066219 label "A Study of Heterologous Vaccine Regimen of Adenovirus Serotype 26 Mosaic4 Human Immunodeficiency Virus(Ad26.Mos4.HIV), Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1 Infection Among Cis-gender Men and Transgender Individuals Who Have" @default.
- Q66066219 label "A Study of Heterologous Vaccine Regimen of Adenovirus Serotype 26 Mosaic4 Human Immunodeficiency Virus(Ad26.Mos4.HIV), Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1 Infection Among Cis-gender Men and Transgender Individuals Who Have" @default.
- Q66066219 altLabel "HPX3002" @default.
- Q66066219 altLabel "HVTN 706" @default.
- Q66066219 altLabel "MOSAICO" @default.
- Q66066219 prefLabel "A Study of Heterologous Vaccine Regimen of Adenovirus Serotype 26 Mosaic4 Human Immunodeficiency Virus(Ad26.Mos4.HIV), Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1 Infection Among Cis-gender Men and Transgender Individuals Who Have" @default.
- Q66066219 prefLabel "A Study of Heterologous Vaccine Regimen of Adenovirus Serotype 26 Mosaic4 Human Immunodeficiency Virus(Ad26.Mos4.HIV), Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1 Infection Among Cis-gender Men and Transgender Individuals Who Have" @default.
- Q66066219 P1132 Q66066219-92837518-FA29-4122-ABED-F63C098E62E8 @default.
- Q66066219 P1476 Q66066219-91564E19-7784-4C42-9670-04311501763C @default.
- Q66066219 P17 Q66066219-0E7DDED0-5A34-4D26-96DD-D8704E7407BD @default.
- Q66066219 P17 Q66066219-1DAFBC7B-DDF8-4BF8-BC6E-08CCC5CE7D7A @default.
- Q66066219 P17 Q66066219-49A0A9C4-10BE-44B8-B15D-B8BCB2A70FED @default.
- Q66066219 P17 Q66066219-5B513A50-A40B-47C1-9C0F-06210D10CAF0 @default.
- Q66066219 P17 Q66066219-893B28E1-6598-4894-B936-B7908573FCDD @default.
- Q66066219 P17 Q66066219-AD72BC64-DBC0-48BB-B1AE-F8ABD8944F25 @default.
- Q66066219 P17 Q66066219-C262C8B3-5883-43C2-B8A7-D87F952E0C04 @default.
- Q66066219 P17 Q66066219-EFE5CE95-8F18-4E8D-967E-D4DD03E55508 @default.
- Q66066219 P1813 Q66066219-43918D5E-5314-4B07-8651-6A78F99E01C2 @default.
- Q66066219 P2899 Q66066219-9BFACBC6-FE67-4168-A206-44BC4413193D @default.
- Q66066219 P3098 Q66066219-67E5C610-F8BE-4ED5-84C8-6050E4CEF998 @default.
- Q66066219 P31 Q66066219-44413E30-3C78-4718-855F-5D34D56C6B33 @default.
- Q66066219 P4135 Q66066219-462CA57D-4EF8-414D-85C5-E81C12825F11 @default.
- Q66066219 P580 Q66066219-46F1C913-C041-41D7-8B7A-2BE9D98938CC @default.
- Q66066219 P582 Q66066219-794B2EDB-1FDB-4DF1-9E0E-1FAE02B74E16 @default.
- Q66066219 P6099 Q66066219-F5009CA8-8319-4479-808D-FE6670D2CB3A @default.
- Q66066219 P6153 Q66066219-17E07E62-070B-4221-B714-DEEF9B2D4A9C @default.
- Q66066219 P6153 Q66066219-1F2F7163-BAB9-410E-B297-6F6464D23BBE @default.
- Q66066219 P6153 Q66066219-304C40C6-277C-4A86-96D5-FAA5FFDCB767 @default.
- Q66066219 P6153 Q66066219-50A304A9-9E64-45EB-ACA5-8F46AF346ACF @default.
- Q66066219 P6153 Q66066219-68749378-C359-41EF-BAE8-18E6D8024D1A @default.
- Q66066219 P6153 Q66066219-6F4032E1-7752-4CD4-B385-997FD5851A69 @default.
- Q66066219 P6153 Q66066219-82A02A05-8187-49E3-B707-C2B73CC58BE4 @default.
- Q66066219 P6153 Q66066219-A1398B23-1443-43AB-8365-C4486A455B88 @default.
- Q66066219 P6153 Q66066219-E5F1FC7C-6409-4A2C-BCB1-5708DDC45193 @default.
- Q66066219 P8363 Q66066219-517DD49D-6C46-4EAE-95A2-1A4F9B499E44 @default.
- Q66066219 P856 Q66066219-73e87756-4b9d-11c5-d473-268dc607e242 @default.
- Q66066219 P1132 "+3800" @default.
- Q66066219 P1476 "A Multi-center, Randomized, Double-blind, Placebo-controlled Phase 3 Efficacy Study of a Heterologous Vaccine Regimen of Ad26.Mos4.HIV and Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1 Infection Among Cis-gender Men and Transgender Individuals Who Have Sex With Cis-gender Men and/or Transgender Individuals" @default.
- Q66066219 P17 Q155 @default.
- Q66066219 P17 Q29 @default.
- Q66066219 P17 Q30 @default.
- Q66066219 P17 Q36 @default.
- Q66066219 P17 Q38 @default.
- Q66066219 P17 Q414 @default.
- Q66066219 P17 Q419 @default.
- Q66066219 P17 Q96 @default.
- Q66066219 P1813 "MOSAICO" @default.
- Q66066219 P2899 "+18" @default.
- Q66066219 P3098 "NCT03964415" @default.
- Q66066219 P31 Q30612 @default.
- Q66066219 P4135 "+60" @default.
- Q66066219 P580 "2019-08-30T00:00:00Z" @default.
- Q66066219 P582 "2023-01-03T00:00:00Z" @default.
- Q66066219 P6099 Q42824827 @default.
- Q66066219 P6153 Q1047060 @default.
- Q66066219 P6153 Q1472663 @default.
- Q66066219 P6153 Q16569958 @default.
- Q66066219 P6153 Q30270271 @default.
- Q66066219 P6153 Q457281 @default.
- Q66066219 P6153 Q49117 @default.
- Q66066219 P6153 Q5443659 @default.
- Q66066219 P6153 Q7013074 @default.
- Q66066219 P6153 Q738258 @default.
- Q66066219 P8363 Q78089383 @default.
- Q66066219 P856 www.mosaicostudy.com @default.